See also this year's filing and all EDGAR filings for this company.
PDF Report 0001232524_2020_Jazz_Pharmaceuticals_plc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001232524, Jazz Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,630,268,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,360,995,000 |
| 2 | PropertyPlantAndEquipmentNet | 131,506,000 |
| 3 | remainder_Assets | 416,128,000 |
| 4 | LiabilitiesCurrent | 364,490,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 736,942,000 |
| 9 | ResearchAndDevelopmentExpense | 409,701,000 |
| 10 | remainder_Expenses | 409,590,000 |
| 11 | remainder_Revenues | 2,161,761,000 |
| 12 | remainder_NetIncome | -82,161,000 |
| 13 | remainder_ComprehensiveNetIncome | -25,602,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,538,897,000 |
| 1 | Liabilities | 364,490,000 |
| 2 | Expenses | 1,556,233,000 |
| 3 | Revenues | 2,161,761,000 |
| 4 | StockholdersEquity | 5,174,407,000 |
| 5 | NetIncome | 523,367,000 |
| 6 | ComprehensiveNetIncome | 510,566,000 |
| 7 | BaseVar | 4,864,572,000 |
| 8 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
